Abstract Library

#4480 Efficacy of regional and systemic therapies for refractory hypoglycaemia in malignant insulinoma

Introduction: Insulinoma is a rare neuroendocrine tumour characterised by inappropriate autonomous insulin secretion.

Conference:

Presenting Author: Koch R

Authors: Koch R, McGarrah P, Eiring R, Hobday T, Halfdanarson T,

Keywords: Insulinoma, radioligand therapy,

#2868 Differential Gene Expression May Predict Response to Somatostatin Analogues (SSAs) in Gastrointestinal (GI) Neuroendocrine Tumors (NETs)

Introduction: SSAs are commonly used to treat GI NETs as they have anti-secretory and antiproliferative effects. However, genetic markers predicting response to SSAs are lacking.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: Teufel A

Authors: Teufel A, Evert K, Itzel T, Evert M, Koch C,

Keywords: NET gene expression profiling, SSA somatostatin analoga,

#2758 Survival According to Therapy Regimen for siNET: Data from 145 Patients from a German Tertiary Referral Centre, Preliminary Results

Introduction: Scarce data exists for therapy regimens other than SSRA and PRRT for siNET.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author:

Authors: Bambey C, Koch C, Filmann N, Husmann G, Bojunga J,

Keywords: siNET, survival, multimodal therapy,

#552 Outcomes After Liver Resection and Multidisciplinary Management of Gastroenteropancreatic Neuroendocrine Tumor Liver Metastases

Introduction: Metastatic liver disease from neuroendocrine tumors (mNETs) has a significant impact on prognosis. Although complete surgical resection remains the only potentially curative therapy, a multimodal approach is becoming the standard by which it is managed.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Fehr A, Bhatia P, Kocha W, Reid R, Elliott J,

Keywords: liver metastases, liver resection, multimodality,

#530 Liver Transplantation for Metastatic Neuroendocrine Tumor: A Case Series and Proposed Selection Criteria

Introduction: Liver transplantation (LT) for neuroendocrine tumor (NET) metastases is associated with a high risk of tumor recurrence. Patient selection is the key to future success and its increased utilization.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Chan G, Kocha W, Reid R, Taqi A, Wall W,

Keywords: liver transplantation, neuroendocrine tumor, metastases,